Previous close | 5.95 |
Open | 5.98 |
Bid | 6.00 x 600 |
Ask | 6.01 x 600 |
Day's range | 5.91 - 6.09 |
52-week range | 4.74 - 9.59 |
Volume | |
Avg. volume | 1,395,590 |
Market cap | 2.292B |
Beta (5Y monthly) | 1.41 |
PE ratio (TTM) | N/A |
EPS (TTM) | -0.51 |
Earnings date | 29 Apr 2024 - 03 May 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 8.79 |
LifeStance Health, one of the nation's largest providers of virtual and in-person outpatient mental healthcare, today announced that Dr. Teresa DeLuca has joined the company's board of directors. Dr. DeLuca is a psychiatrist and accomplished physician executive with over 20 years of leadership experience, having held senior executive leadership roles at Magellan Health, Humana and Walgreens, and brings extensive healthcare operations and clinical management expertise to LifeStance's board of dir
The investors in LifeStance Health Group, Inc. 's ( NASDAQ:LFST ) will be rubbing their hands together with glee today...
Key Insights Using the 2 Stage Free Cash Flow to Equity, LifeStance Health Group fair value estimate is US$7.51 Current...